Nighttime Agitation and Restless Leg Syndrome in Alzheimer's Disease Clinical Trial Data

Replication data from a clinical trial investigating restless legs syndrome as a mechanism for nighttime agitation in persons with Alzheimer's disease. The dataset was authored by Kathy Richards and harvested from the Texas Data Repository on March 18, 2024. It likely contains measurements related to agitation, sleep quality, and medication use.

Use Cases

• Analyze the relationship between restless legs syndrome and nighttime agitation based on the clinical trial's primary hypothesis.
• Evaluate the effect of gabapentin enacarbil treatment on antipsychotic medication reduction as described in the study.
• Model changes in sleep quality and restless legs syndrome behaviors following the intervention mentioned in the description.

Strengths

• Data originates from a structured clinical trial with a clear research hypothesis.
• Last updated on March 18, 2024, indicating recent metadata activity.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

Texas Data Repository Harvested Dataverse

Collection Method

Clinical trial data, likely collected as part of a proposed study.

Time Range

null

Freshness

Last updated 2024-03-18 07:11:05; freshness should be verified

Geography

null